Mon, 21st Sep 2020 21:19
Ovoca Bio PLC - Women's health-focused biopharmaceutical company - Like last year, posts no revenue in six months to June 30. Pretax loss widens to EUR2.0 million from EUR439,000. Posts EUR1.1 million in other losses, compared to gains to EUR463,000 a year earlier.
Current stock price: 14.00 pence
Year-to-date change: up 19%
By Eric Cunha; ericcunha@alliancenews.com
Copyright 2020 Alliance News Limited. All Rights Reserved.
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:
(Alliance News) - Stock prices in London closed mixed on Thursday, after news that a key US inflation reading came in in line with market expectations...
(Sharecast News) - Biopharmaceutical developer Ovoca Bio's shares were plummeting on Thursday, after it released a summary of the top-line results fro...
(Alliance News) - Ovoca Bio PLC shares plummeted on Thursday, after it said that a study into Orenetide did not show statistically significant superio...
Ovoca Bio (OVB)